Es gab 50 kürzliche Insider-Transaktionen für Cardiff Oncology, Inc. (CRDF), darunter 47 Käufe und 1 Verkauf. Die gesamten Insider-Käufe beliefen sich auf $16.4M und die gesamten Insider-Verkäufe auf $743.75K.
Bedeutende Insider mit kürzlicher Aktivität umfassen Mohindru Mani, Lindsay Brigitte Ute, Pace Gary W. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — CRDF
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2026-03-31 |
Mohindru Mani |
Chief Executive Officer |
RSU-Zuteilung |
600,000 |
$1.62 |
$972K |
968,766 |
| 2026-02-17 |
Mohindru Mani |
Interim CEO |
RSU-Zuteilung |
200,000 |
$1.56 |
$312K |
368,766 |
| 2026-02-13 |
Lindsay Brigitte Ute |
Chief Accounting Officer |
RSU-Zuteilung |
200,000 |
$1.60 |
$320K |
1,025,334 |
| 2026-01-27 |
Lindsay Brigitte Ute |
Chief Accounting Officer |
Unbekannt |
166,320 |
$3.58 |
$595.43K |
- |
| 2025-07-30 |
Pace Gary W |
Director |
Informierter Kauf |
275,000 |
$2.45 |
$673.75K |
1,330,676 |
| 2025-06-26 |
Pace Gary W |
Director |
RSU-Zuteilung |
40,565 |
$3.16 |
$128.19K |
187,539 |
| 2025-06-26 |
Armitage James O |
Director |
RSU-Zuteilung |
40,565 |
$3.16 |
$128.19K |
187,539 |
| 2025-06-26 |
White Lale |
Director |
RSU-Zuteilung |
40,565 |
$3.16 |
$128.19K |
158,681 |
| 2025-06-26 |
Markin Rodney S |
Director |
RSU-Zuteilung |
40,565 |
$3.16 |
$128.19K |
222,865 |
| 2025-06-26 |
Tannenbaum Renee P |
Director |
RSU-Zuteilung |
40,565 |
$3.16 |
$128.19K |
168,766 |
| 2025-06-26 |
Mohindru Mani |
Director |
RSU-Zuteilung |
40,565 |
$3.16 |
$128.19K |
168,766 |
| 2025-06-16 |
Sidhu Roger |
Chief Medical Officer |
Unbekannt |
600,000 |
$3.86 |
$2.32M |
- |
| 2025-03-11 |
Levine James E. |
Chief Financial Officer |
RSU-Zuteilung |
332,621 |
$3.58 |
$1.19M |
1,295,117 |
| 2025-03-11 |
Erlander Mark |
Chief Executive Officer |
RSU-Zuteilung |
758,400 |
$3.58 |
$2.72M |
2,925,098 |
| 2025-03-11 |
Kabbinavar Fairooz |
Chief Medical Officer |
RSU-Zuteilung |
150,000 |
$3.58 |
$537K |
780,008 |
| 2025-03-11 |
Smeal Tod |
Chief Scientific Officer |
RSU-Zuteilung |
332,621 |
$3.58 |
$1.19M |
979,805 |
| 2024-12-18 |
Levine James E. |
Chief Financial Officer |
Informierter Kauf |
2,400 |
$5.00 |
$12K |
67,716 |
| 2024-12-17 |
Levine James E. |
Chief Financial Officer |
Informierter Kauf |
2,752 |
$5.42 |
$14.91K |
65,316 |
| 2024-12-16 |
Levine James E. |
Chief Financial Officer |
Informierter Kauf |
2,564 |
$3.83 |
$9.82K |
62,564 |
| 2024-12-12 |
Tannenbaum Renee P |
Director |
Informierter Kauf |
10,000 |
$3.42 |
$34.22K |
20,000 |
| 2024-12-11 |
Pace Gary W |
Director |
Informierter Kauf |
350,115 |
$2.60 |
$910.3K |
1,047,876 |
| 2024-06-27 |
Pace Gary W |
Director |
RSU-Zuteilung |
29,700 |
$2.33 |
$69.2K |
146,974 |
| 2024-06-27 |
Armitage James O |
Director |
RSU-Zuteilung |
29,700 |
$2.33 |
$69.2K |
146,974 |
| 2024-06-27 |
Markin Rodney S |
Director |
RSU-Zuteilung |
29,700 |
$2.33 |
$69.2K |
182,027 |
| 2024-06-27 |
Tannenbaum Renee P |
Director |
RSU-Zuteilung |
29,700 |
$2.33 |
$69.2K |
128,201 |
| 2024-06-27 |
White Lale |
Director |
RSU-Zuteilung |
29,700 |
$2.33 |
$69.2K |
146,974 |
| 2024-06-27 |
Mohindru Mani |
Director |
RSU-Zuteilung |
29,700 |
$2.33 |
$69.2K |
128,201 |
| 2024-03-07 |
Levine James E. |
Chief Financial Officer |
RSU-Zuteilung |
205,008 |
$3.51 |
$719.58K |
962,496 |
| 2024-03-07 |
Erlander Mark |
Chief Executive Officer |
RSU-Zuteilung |
510,000 |
$3.51 |
$1.79M |
2,170,310 |
| 2024-03-07 |
Kabbinavar Fairooz |
Chief Medical Officer |
RSU-Zuteilung |
205,008 |
$3.51 |
$719.58K |
630,008 |
| 2024-03-07 |
Smeal Tod |
Chief Scientific Officer |
RSU-Zuteilung |
205,008 |
$3.51 |
$719.58K |
647,184 |
| 2023-12-19 |
Pace Gary W |
Director |
Informierter Kauf |
30,000 |
$1.37 |
$41.1K |
697,761 |
| 2023-11-10 |
Pace Gary W |
Director |
Informierter Kauf |
22,950 |
$0.98 |
$22.49K |
667,761 |
| 2023-06-15 |
Pace Gary W |
Director |
RSU-Zuteilung |
27,700 |
$1.59 |
$44.04K |
117,274 |
| 2023-06-15 |
Armitage James O |
Director |
RSU-Zuteilung |
27,700 |
$1.59 |
$44.04K |
117,274 |
| 2023-06-15 |
Markin Rodney S |
Director |
RSU-Zuteilung |
27,700 |
$1.59 |
$44.04K |
152,327 |
| 2023-06-15 |
Tannenbaum Renee P |
Director |
RSU-Zuteilung |
27,700 |
$1.59 |
$44.04K |
98,501 |
| 2023-06-15 |
White Lale |
Director |
RSU-Zuteilung |
27,700 |
$1.59 |
$44.04K |
117,274 |
| 2023-06-15 |
Mohindru Mani |
Director |
RSU-Zuteilung |
27,700 |
$1.59 |
$44.04K |
98,501 |
| 2023-03-15 |
Levine James E. |
Chief Financial Officer |
RSU-Zuteilung |
197,472 |
$1.72 |
$339.65K |
757,488 |
| 2023-03-15 |
Erlander Mark |
Chief Executive Officer |
RSU-Zuteilung |
482,064 |
$1.72 |
$829.15K |
1,664,477 |
| 2023-03-15 |
Kelemen Vicki |
Exec. VP and COO |
RSU-Zuteilung |
125,520 |
$1.72 |
$215.89K |
698,304 |
| 2023-03-15 |
Smeal Tod |
Chief Scientific Officer |
RSU-Zuteilung |
167,088 |
$1.72 |
$287.39K |
442,176 |
| 2023-01-30 |
Kabbinavar Fairooz |
Chief Medical Officer |
Veräußerung |
425,000 |
$1.75 |
$743.75K |
- |
| 2022-11-25 |
Erlander Mark |
Chief Executive Officer |
Informierter Kauf |
10,000 |
$1.43 |
$14.3K |
24,481 |
| 2022-09-19 |
White Lale |
Director |
Informierter Kauf |
15,000 |
$1.64 |
$24.53K |
113,788 |
| 2022-09-16 |
Levine James E. |
Chief Financial Officer |
Informierter Kauf |
30,000 |
$1.56 |
$46.71K |
60,000 |
| 2022-09-16 |
Armitage James O |
Director |
Informierter Kauf |
13,000 |
$1.56 |
$20.23K |
13,000 |
| 2022-09-15 |
Pace Gary W |
Director |
Informierter Kauf |
150,000 |
$1.71 |
$256.5K |
644,811 |
| 2022-09-15 |
Tannenbaum Renee P |
Director |
Informierter Kauf |
6,400 |
$1.72 |
$10.98K |
6,400 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
